The Food and Drug Administration is preparing to launch a study of how well consumers understand the lengthy list of safety risks listed in drug advertisements — and whether there are so many warnings that their eyes glaze over.

But the study, and related work at the FDA, have irked the drug industry and spurred critics of direct-to-consumer drug advertisements to argue the agency should be doing more.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Drug ads don’t belong on TV, newspapers, magazines, or social media. Period. It just raises costs to consumers. Exactly how many patoents need Keytruda or Opdivo anyway?

    • I agree completely. First, by the time they are through you’ve been convinced that any good they do is offset by the side effects and they also give false hope to many individuals, plus then every patient wants the newest most expensive drug for their condition whether it works or not. Do away with them altogether.

    • The commercial that always gives me a chuckle is the one that warns against taking the drug if you have multiple endocrineal neoplasia type 2. How many people actually know what that is? Ask your doctor whether STATNEWS is right for you!

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy